TREATMENT, DIAGNOSIS, AND ADEQUATE PREVENTION OF IRON DEFICIENCIES IN THE PRACTICE OF AN OBSTETRICIAN/GYNECOLOGIST
The paper considers the specific features of iron metabolism in pregnancy, the principles of laboratory diagnosis, prevention, and treatment of IDA. At the present time, WHO experts recommend using oral sustained-release ferrous iron preparations for the treatment of iron deficiencies. The paper presents the authors' experience with ferretab comp. in preventing and treating IDA in obstetric/gynecologic practice. One capsule of the drug contains 163.56 mg ferrous furamate and 0.54 mg folic acid. Ferretab comp. is used in any degree of IDA caused by pregnancy, uterine myoma, adenomyosis, endometrial hyperplastic processes, and other gynecological diseases.